Continuum Advisory »

Allogene Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5k 612 2.46
2024-06-30 $1.3k 550 2.33
2024-03-31 $1.6k 550 2.86

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Vanguard Total Stock Market Etf Etf (VTI)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Nvidia Corporation Stock (NVDA)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)

View all positions for Continuum Advisory

Top funds holding Allogene Therapeutics

Tpg Gp A
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
PRIMECAP Management Company
Citadel Advisors
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Investments
Wildcat Capital Management

View all funds holding Allogene Therapeutics